The Center for Intelligent Imaging, or ci2, will develop and apply AI to devise powerful new ways to look inside the body and to evaluate health and disease. Investigators in ci2 will team with Santa Clara, Calif.-based NVIDIA Corp., an industry leader in AI computing, to build infrastructure and tools focused on enabling the translation of AI into clinical practice.
The center also will link academic innovation to startups to promote collaborative AI imaging research and development. The inaugural start-up company to leverage ci2 in this capacity is London-based Kheiron Medical Technologies, Ltd., which will work with the UCSF breast imaging group to ensure that its MiaTM breast cancer screening software can be safely and feasibly deployed in ethnically diverse populations.
“Breast cancer affects every woman’s life, either directly or indirectly,” said Bonnie Joe, MD, PhD, professor of radiology and chief of breast imaging in the department. “The impact of AI is magnified through its application to breast imaging. Augmenting the radiologist’s ability to detect breast cancer early will help us make a dent in this deadly disease.”
“ci2 is unique in its focus of accelerating the translation of AI from the laboratory to the bedside, putting AI software through its paces to make sure it is safe and effective for patients,” said Peter Kecskemethy, chief executive officer of Kheiron Medical. “Together, we believe we can help usher in a new age of cancer care when AI-supported cancer diagnostics and workflows enable doctors to provide earlier and more accurate detection and tracking, and better outcomes for patients across the globe.”
Contact information:
www.www.kheironmed.com
Blog
8th September 2021
In 2020, more than 2.2 million cases of breast cancer were diagnosed. Kheiron Medical Company develops a platform for early cancer screening. ...
Read moreBlog
8th August 2021
Dr. Nisha Sharma discusses 'Role of AI in Breast Screening' at RANZCR New Zealand's 2021 annual meeting. ...
Read moreBlog
7th August 2021
The UK's National Health Service has been under strain for years - and then the pandemic hit. Could artificial intelligence and its applications be the NHS's saviour?...
Read moreArticle
2nd August 2021
Partnership with Hospital Services Limited to bring AI - enabled breast screening solution Mia to breast screen programmes across Ireland...
Read morePR
25th July 2021
Kheiron Medical Technologies partners with Medtech Corporation to bring AI breast screening solution Mia® to Qatar healthcare community....
Read moreBlog
12th July 2021
Higher workloads. New responsibilities. The pandemic has forced staff to stretch their responsibilities across departments and tackle new ways of working...
Read moreBlog
12th July 2021
The COVID-19 pandemic had a severe, global effect on breast screening efforts....
Read moreArticle
8th July 2021
The safe adoption of AI can benefit mammography departments as they strive to deliver on the goals of the national breast screening program....
Read morePR
5th July 2021
Kheiron Medical Technologies partners with Atlas Medical to bring AI breast screening solution Mia® to UAE healthcare community....
Read more